TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.5 BREAKDOWN OF PRIMARY RESPONDENTS
3.6 FORECASTING TECHNIQUES
3.7 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.7.1 BOTTOM-UP APPROACH
3.7.2 TOP-DOWN APPROACH
3.8 DATA TRIANGULATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF SLEEP BRUXISM
4.2.2 GROWING CHILD POPULATION
4.2.3 RISING PREVALENCE OF OBSTRUCTIVE SLEEP APNEA
4.2.4 LIFESTYLE CHANGES
4.3 RESTRAINT
4.3.1 LIMITED AVAILABILITY OF TREATMENT OPTIONS
4.4 OPPORTUNITY
4.4.1 UNTAPPED MARKETS IN ASIA-PACIFIC
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D AND DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES REVIEW
5.2 FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF BUYERS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19
5.3.1 IMPACT ON POPULATION HEALTH
5.3.2 IMPACT ON DEMAND
6 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRIMARY BRUXISM
6.3 SECONDARY BRUXISM
7 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE
7.1 OVERVIEW
7.2 OBSTRUCTIVE SLEEP APNEA
7.3 GASTROESOPHAGEAL REFLUX DISEASE
7.4 MALOCCLUSION
7.5 SLEEP PARALYSIS
8 GLOBAL SLEEPING BRUXISM TREATMENT MARKET BY TREATMENT
8.1 OVERVIEW
8.2 DENTAL APPROACHES
8.2.1 MOUTH GUARD
8.2.2 NTI-TSS DEVICE
8.3 MEDICATION
8.3.1 MUSCLE RELAXANTS
8.3.2 Botulinum Toxin Type A INJECTIONS
8.3.3 ANTI-ANXIETY DRUGS
9 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE
9.1 OVERVIEW
9.2 PAEDIATRIC
9.3 ADULT
9.3.1 MALE
9.3.2 FEMALE
10 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS
10.3 DENTAL CLINICS
11 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION
11.1 INTRODUCTION
11.2 AMERICAS
11.2.1 NORTH AMERICA
11.2.1.1 US
11.2.1.2 CANADA
11.2.2 LATIN AMERICA
11.3 EUROPE
11.3.1 WESTERN EUROPE
11.3.1.1 GERMANY
11.3.1.2 FRANCE
11.3.1.3 UK
11.3.1.4 SCANDINAVIA
11.3.1.4.1 KINGDOM OF DENMARK
11.3.1.4.2 NORWAY
11.3.1.4.3 SWEDEN
11.3.1.4.4 FINLAND
11.3.1.4.5 ICELAND
11.3.1.5 BENELUX UNION
11.3.1.5.1 BELGIUM
11.3.1.5.2 NETHERLANDS
11.3.1.5.3 LUXEMBOURG
11.3.1.6 ITALY
11.3.1.7 SPAIN
11.3.1.8 SWITZERLAND
11.3.1.9 REST OF WESTERN EUROPE
11.3.2 EASTERN EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 INDIA
11.4.3 JAPAN
11.4.4 SOUTH KOREA
11.4.5 REST OF ASIA PACIFIC
11.5 MIDDLE EAST & AFRICA
11.5.1 MIDDLE EAST
11.5.2 AFRICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
12.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL SLEEPING BRUXISM TREATMENT MARKET
12.5 KEY DEVELOPMENT ANALYSIS
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT LAUNCH
12.6.2 ACQUISITION
12.6.3 PARTNERSHIP
12.7 MAJOR PLAYERS FINANCIAL MATRIX
12.7.1 SALES & OPERATING INCOME MARGIN (USD MILLION), 2020
12.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020
13 COMPANY PROFILES
13.1 IVOCLAR VIVADENT AG
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS/SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 IPSEN S.A.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS/SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 MERZ PHARMA GMBH & CO. KGAA
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS/SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 CARESTREAM DENTAL
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS/SERVICES OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 SWOT ANALYSIS
13.4.6 KEY STRATEGIES
13.5 AKERVALL TECHNOLOGIES INC.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS/SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 PLANMECA OY
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS/SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 RANDMARK DENTAL PRODUCTS, LLC
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS/SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 S4S (UK) LIMITED
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS/SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGIES
13.9 PATTERSON DENTAL SUPPLY, INC.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS/SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 HENRY SCHEIN, INC.
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS/SERVICES OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 SWOT ANALYSIS
13.10.6 KEY STRATEGIES
13.11 PFIZER, INC.
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 PRODUCTS/SERVICES OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 SWOT ANALYSIS
13.11.6 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018–2027 (USD MILLION)
TABLE 3 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR PRIMARY BRUXISM, BY REGION, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR SECONDARY BRUXISM, BY REGION, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET FOR OBSTRUCTIVE SLEEP APNEA, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MALOCCLUSION, BY REGION, 2018–2027 (USD MILLION)
TABLE 9 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR SLEEP PARALYSIS, BY REGION, 2018–2027 (USD MILLION)
TABLE 10 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT TYPE, 2018-2027 (USD MILLION)
TABLE 11 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TREATMENT TYPE 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MOUTH GUARD, BY REGION, 2018–2027 (USD MILLION)
TABLE 14 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR NTI-TSS DEVICE, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY REGION, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TREATMENT TYPE 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR MUSCLE RELAXANTS, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR BINJECTIONS, BY REGION, 2018–2027 (USD MILLION)
TABLE 19 GLOBAL: SLEEPING BRUXISM TREATMENT MARKET, FOR ANTI-ANXIETY DRUGS, BY REGION, 2018–2027 (USD MILLION)
TABLE 20 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 21 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR PAEDIATRIC, BY REGION 2018-2027 (USD MILLION)
TABLE 22 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY REGION 2018-2027 (USD MILLION)
TABLE 23 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, FOR ADULT, 2018-2027 (USD MILLION)
TABLE 24 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, FOR MALE, BY REGION 2018-2027 (USD MILLION)
TABLE 25 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY ADULT, FOR FEMALE, BY REGION 2018-2027 (USD MILLION)
TABLE 26 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 27 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 30 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 31 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 32 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 33 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 34 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 35 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 36 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 37 GLOBAL SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 38 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
TABLE 39 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 40 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 41 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 42 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 43 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 44 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 45 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46 AMERICAS SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 47 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 48 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 49 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 50 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 52 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 53 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 54 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 55 NORTH AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 56 US SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 57 US SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 58 US SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 59 US SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 60 US SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 61 US SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 62 US SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 63 US SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 64 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 65 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 66 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 67 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 68 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 69 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 70 CANADA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 71 CANADA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
TABLE 72 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
TABLE 73 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 74 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR DENTAL APPROACHES, BY TYPE, 2018-2027 (USD MILLION)
TABLE 75 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2018-2027 (USD MILLION)
TABLE 76 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY CAUSE, 2018-2027 (USD MILLION)
TABLE 77 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY PATIENT TYPE, 2018-2027 (USD MILLION)
TABLE 78 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, FOR ADULT, BY TYPE, 2018-2027 (USD MILLION)
TABLE 79 LATIN AMERICA SLEEPING BRUXISM TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLI
